<?xml version="1.0" encoding="UTF-8"?>
<Label drug="phendimetrazine" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  The following adverse reactions are described, or described in greater detail, in other sections:



 - Primary pulmonary hypertension (see  Warnings  )



 - Valvular heart disease (see  Warnings  )



 -Effect on the ability to engage in potentially hazardous tasks (see  Warnings  )



 -Withdrawal effects following prolonged high dosage administration (see  Drug Abuse and Dependence  )



 The following adverse reactions to phendimetrazine have been identified:



   Cardiovascular

  Primary pulmonary hypertension and/or regurgitant cardiac valvular disease, palpitation, tachycardia, elevated blood pressure, ischemic events.



   Central Nervous System

  Overstimulation, restlessness, insomnia, agitation, flushing, tremor, sweating, dizziness, headache, psychotic state, blurring of vision.



   Gastrointestinal

  Dryness of the mouth, nausea, stomach pain, diarrhea, constipation,



   Genitourinary

  Urinary frequency, dysuria, changes in libido.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
